Rancho Mirage, CA2 Active Studies

Ankylosing Spondylitis Clinical Trials in Rancho Mirage, CA

Find 2 actively recruiting ankylosing spondylitis clinical trials in Rancho Mirage, CA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
731
Enrolling

Recruiting Ankylosing Spondylitis Studies in Rancho Mirage

About Ankylosing Spondylitis Clinical Trials in Rancho Mirage

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 2 ankylosing spondylitis clinical trials recruiting participants in Rancho Mirage, CA. These studies are seeking a combined 731 participants. Research is being sponsored by Alexion Pharmaceuticals, Inc., Immunovant Sciences GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Rancho Mirage — FAQ

Are there ankylosing spondylitis clinical trials in Rancho Mirage?

Yes, there are 2 ankylosing spondylitis clinical trials currently recruiting in Rancho Mirage, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rancho Mirage?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rancho Mirage research site will contact you about next steps.

Are clinical trials in Rancho Mirage free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rancho Mirage studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 2 active trials in Rancho Mirage are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 13, 2026 from ClinicalTrials.gov